Trilaciclib Injection [Cosela]

DRUG3 trials

Sponsors

The First Affiliated Hospital with Nanjing Medical University, Fudan University

Conditions

ESCCEsophageal CancerEwing SarcomaMyelosuppression

Phase 2

Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer

RecruitingNCT06569459

The First Affiliated Hospital with Nanjing Medical UniversityEsophageal Cancer

Start: 2024-07-09End: 2026-07-31Target: 60Updated: 2024-08-26

A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib

RecruitingNCT06699472

Fudan UniversityEwing Sarcoma, Myelosuppression

Start: 2024-10-31End: 2027-09-30Target: 22Updated: 2024-11-21

Unknown Phase

Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma

RecruitingNCT06698692

The First Affiliated Hospital with Nanjing Medical UniversityESCC

Start: 2024-04-02End: 2025-04-02Target: 200Updated: 2024-11-21